Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.
about
Epicardial-myocardial signaling directing coronary vasculogenesisAngiopoietin-1-induced ubiquitylation of Tie2 by c-Cbl is required for internalization and degradationAnti-angiogenic alternatives to VEGF blockadeCorneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)Von Willebrand factor, angiodysplasia and angiogenesisMechanisms regulating endothelial permeabilityReceptor tyrosine kinase-mediated angiogenesisMolecular control of endothelial cell behaviour during blood vessel morphogenesisResistance and escape from antiangiogenesis therapy: clinical implications and future strategiesSpheroid Culture of Mesenchymal Stem CellsPathogenesis of herpes stromal keratitis--a focus on corneal neovascularizationMetabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentialityDietary supplementation with omega-3 polyunsaturated fatty acids robustly promotes neurovascular restorative dynamics and improves neurological functions after stroke.Angiopoietin-2-induced blood-brain barrier compromise and increased stroke size are rescued by VE-PTP-dependent restoration of Tie2 signaling.Rapamycin improves TIE2-mutated venous malformation in murine model and human subjectsAngiopoietin-Tie signalling in the cardiovascular and lymphatic systemsEndothelial Response to Glucocorticoids in Inflammatory DiseasesCirculating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary HypertensionSchlemm's canal is a unique vessel with a combination of blood vascular and lymphatic phenotypes that forms by a novel developmental processA lymphatic defect causes ocular hypertension and glaucoma in miceGnRH agonist for triggering of final oocyte maturation: time for a change of practice?Tumor endothelial cell-specific drug delivery system using apelin-conjugated liposomesBMPR2 is required for postimplantation uterine function and pregnancy maintenanceAbl kinases are required for vascular function, Tie2 expression, and angiopoietin-1-mediated survivalMig-6 is required for appropriate lung development and to ensure normal adult lung homeostasisAngiopoietin-2 is a direct transcriptional target of TAL1, LYL1 and LMO2 in endothelial cellsEnsemble analysis of angiogenic growth in three-dimensional microfluidic cell culturesCirculating angiopoietin-2 as a biomarker in ANCA-associated vasculitisSustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdownIn Silico Exploration for Novel Type-I Inhibitors of Tie-2/TEK: The Performance of Different Selection Strategy in Selecting Virtual Screening CandidatesMolecular mechanisms and clinical applications of angiogenesisThe Synthetic Tie2 Agonist Peptide Vasculotide Protects Renal Vascular Barrier Function In Experimental Acute Kidney Injury.Vascular normalization as a therapeutic strategy for malignant and nonmalignant disease.Normalization of the vasculature for treatment of cancer and other diseases.Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation.Angiopoietin-2 stimulation of endothelial cells induces alphavbeta3 integrin internalization and degradationAngiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.In vitro engineering of vascularized tissue surrogates.VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formationNormalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers.
P2860
Q24303956-27597734-D72D-4112-85ED-D2C6A8DAABEBQ24336384-434A88D9-1327-4666-AF52-76D7FEA0D1C4Q26775947-D691F848-FF87-4F5A-8E22-745C982AED95Q26823757-02259D46-4A96-48EC-B850-260A793E69EBQ26852889-0BC287D2-EAD6-4ACA-9BF1-706D7F687178Q26866511-1572DEC9-49EB-4467-9AA6-68F39079961CQ27001612-954B8510-8072-475B-B3AA-6F8AA277F290Q27007664-E28A6424-F335-4EBE-8530-E69281B1E680Q27016629-2FF4403B-BB0D-40BE-8F13-EDB804948A51Q27023276-3F48E930-64F3-44CD-9663-BF5BB8BC5BB8Q27023951-B2BB80E3-4461-474C-A164-2D0CDFF91FCEQ27025007-FDD5C645-2AFF-43E2-AD64-8E88575DA171Q27311387-0EA0A5DB-551D-4235-AE91-3C30424035DAQ27322343-C0477E6C-C0FA-4140-AE7D-6E6CB665B6CEQ27333126-AEF21E1B-632D-4A88-9D7C-EEFDDBAF3EDDQ28070234-519FF508-6D2A-459B-82B5-F55F4BF78E22Q28073947-58DCFC1C-3D9A-4C45-AC08-A1DDF253FDF7Q28109687-AEC7A53A-4E4F-47C2-8B36-AC66A692CFC9Q28244469-DD62103F-031D-4FD4-9F0D-56A4D93AC088Q28247543-04FD5F7E-7D83-49BF-AD0B-51C6B675CE41Q28308094-A4FCDD09-F958-46B1-B4AD-FA43584E8DB8Q28533945-29E34FEE-30A3-40B1-8F15-0DC10D58CDB0Q28586452-01233FCF-0952-44C0-B4E5-910B947BA752Q28586705-06139396-5AB0-42FA-979E-526280F71F07Q28587589-BBB89211-645F-49D3-B350-3CD0ED4BD379Q28727442-A3279BD4-131A-42EB-A421-9932000BB41EQ28729177-CCDA11A6-0159-41A9-AF14-2FDAA4189C8EQ28732725-CF00639E-0BB4-418F-82F4-D0EE90EF0C19Q28817495-704651DA-0D91-4693-B803-063828D5ADD9Q28820755-ABE7FAE9-DB2E-4ACC-81D0-28B16DEF7ADBQ29547314-BD044828-2CD3-4996-B523-27B0C1FD444CQ30389402-671D84C6-01DA-46F5-BB6C-B318CDD1848FQ30469815-79D145DA-50C3-44ED-B67C-2715D14E1C07Q30471456-1A1C4A0A-1102-4A89-A86A-C8D3DE9706B7Q30492193-A576557A-1148-4034-97AB-B3C9656E8C18Q30495730-C5CE55B9-4DFC-46F7-A18E-8989642672EEQ30514534-10FDADA9-5E33-472D-95BD-51D42FC847D7Q30536172-5175F380-5C8D-44BB-8605-5FB14AFAA042Q30539522-8CBF3A21-3996-4367-B1F2-52404E52C7F2Q30542073-BB00EEA3-5291-470B-9087-701201325355
P2860
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.
@en
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.
@nl
type
label
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.
@en
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.
@nl
prefLabel
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.
@en
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.
@nl
P356
P1476
Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.
@en
P2093
Gavin Thurston
Gou Young Koh
P2888
P304
P356
10.1038/NRM2639
P577
2009-03-01T00:00:00Z